Remove board Remove development Remove digital therapeutics Remove support
article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 113
article thumbnail

metaMe Health Raises $2.2M in Funding

HPA

We’re excited to share that metaMe Health , a prescription digital therapeutics (PDT) company, today announced raising $2.2M metaMe Health is the developer of Regulora®, the first FDA-authorized PDT specifically for abdominal pain associated with Irritable Bowel Syndrome (IBS) in adults. in funding.

health 91
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MedRhythms Uses the Universal Language of Music to Bring Hope, Healing to Mobility Impaired Patients

Angel Capital Association

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. How does MedRhythms’ technology work?

article thumbnail

FDA: Orientation for Early Stage Startups

Y Combinator

The FDA is the federal regulatory body in the United States that oversees the development of medical products (e.g. Developing and bringing a product to market will, with the exception of a limited class of products 1 , require explicit FDA marketing approval. We describe the major ones here: Therapeutic Submissions.

startup 59